Kidney Care Community News

I was disappointed that the recent decision by the Cardiovascular and Renal Drugs Advisory Committee of the FDA will further delay the availability of an orally administered agent for anemia treatment in patients with chronic kidney disease.

In April, I became a living kidney donor.

One of the challenges health care providers face in administering COVID-19 vaccines is vaccine hesitancy, especially among disadvantaged populations.

The National Kidney Foundation and the Alport Syndrome Foundation will collaborate on an effort to expand research opportunities for patients with the rare kidney disease.

The American Kidney Fund has launched two online resources for health care professionals that can serve as tools for improving patient adherence to dietary recommendations and increasing awareness of secondary hyperparathyroidism.

A joint study conducted by the National Kidney Foundation and Labcorp revealed that 80.3% of patients who should have been tested for chronic kidney disease according to clinical practice guidelines did not receive appropriate testing.

NephroSant, a startup operating out of the University of California, San Francisco that developed a test to detect graft rejection following kidney transplantation, has hired Gina Ford, RPh, MBA, as its new chief commercialization officer.

Minnesota-based company Nuwellis Inc. announced that it will begin development on a continuous renal replacement therapy device designed specifically for infants and small children with kidney failure.

Cricket Health has closed an $83.5 million Series B funding round, setting the stage for the company to expand and improve care for patients with kidney disease across the United States, according to a press release.

An analysis of NIH records indicates substantial demographic changes have occurred in the physician-scientist workforce conducting kidney research in the United States during the past 30 years.